lobbying_activities: 926405

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id filing_uuid filing_type registrant_name registrant_id client_name filing_year filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
926405 dde5bf94-56f9-4e04-aae5-82e8eed764e8 Q1 AVENUE SOLUTIONS 72111 EXPRESS SCRIPTS INC 2010 first_quarter PHA HR 1204, Community Pharmacy Fairness Act - antitrust exemption for pharmacies; HR 1427, Promoting Innovation and Access to Life Saving Medicine Act - generic biologics; HR 1548, Pathway for Biosimilars Act - generic biologics; HR 1706, Protecting Consumer Access to Generic Drugs Act - generic drugs; HR 3200, America's Affordable Health Choices Act - medication therapy management, RDS (retiree prescription drug coverage), IVIG (intravenous immune globulin), transparency, data minimg, pharmaceutical benefit manager excise tax, generic biologics; HR 3590, Patient Protection and Affordable Care Act - medication therapy management, RDS (retiree prescription drug coverage), IVIG (intravenous immune globulin), transparency, data mining, pharmaceutical benefit manager excise tax, generic biologics; HR 3962, Affordable Health Care for America Act - medication therapy management, RDS (retiree prescription drug coverage), IVIG (intravenous immune globulin), transparency, data mining, pharmaceutical benefit manager excise tax, generic biologics, generic prescription drugs; HR 4489, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act HR 4872, Health Care and Education Reconciliation Act - medication therapy management, RDS (retiree prescription drug coverage), IVIG (intravenous immune globulin), transparency, data mining, pharmaceutical benefit manager excise tax, generic biologics; S. 369, Preserve Access to Affordable Generics Act - generic drugs; S 726, Promoting Innovation and Access to Life-Saving Medicine Act - generic biologics; S 1630, Affordable Access to Prescription Medications Act - prescription drug co-pays and formularies; S 1679, Affordable Health Choices Act - medication therapy management, RDS (retiree prescription drug coverage), IVIG (intravenous immune globulin), transparency, data mining, pharmaceutical benefit manager excise tax, generic biologics; S 1796, American's Healthy Future Act - medication therapy management, RDS (retiree prescription drug coverage), IVIG (intravenous immune globulin), transparency, data mining, pharmaceutical benefit manager excise tax, generic biologics Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2010-04-19T22:02:05.403000-04:00